The customer stated that they were made aware of a product recall from an abbott competitor regarding assay interference from n-acetyl cysteine (nac) with assays including glucose, lactic acid, uric acid and triglycerides.Upon doing research on the (b)(4), the customer found similar recalls from other competitors (beckman coulter, roche and siemens) over the past 18 months but nothing from abbott laboratories.The customer inquired as to whether abbott has any information regarding similar interference with architect assays.No discrepant architect patient results or impact to patient management was reported.
|